Accolade Inc reports results for the quarter ended in February - Earnings Summary

• Accolade Inc ACCD reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended in February, higher than the same quarter last year, when the company reported EPS of -42 cents. The mean expectation of sixteen analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -16 cents to 10 cents per share.

• Revenue rose 26.1% to $124.83 million from a year ago; analysts expected $123.91 million.

• Accolade Inc's reported EPS for the quarter was a loss of 10 cents​.

• The company reported a quarterly loss of $7.51 million.

• Accolade Inc shares had fallen by 10.3% this quarter and lost 21.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 8.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Accolade Inc is $16.00

This summary was machine generated from LSEG data April 25 at 11:12 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)